Vir Biotechnology Presents New Data Evaluating the
– Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomodulator...
Source: globenewswire.com
📰 Florian Lempp News
Florian Lempp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Florian Lempp. Real-time updates on events, politics, business and more.
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023
– Data support the potential impact of VIR-2218 and VIR-3434 in addressing both HBV and HDV and underscore the Company’s confidence in its approach to a functional cure for HBV – SAN... | June 7, 2023
Source: marketscreener.com